Findings at 10 weeks after start of induction therapy in the first-line IFX group versus the conventional treatment group
| First-line IFX | Conventional | P value | |
| Fcal (µg/g), median (IQR) | 286 (62–596) | 545 (279–1108) | 0.004 |
| Patients with Fcal <100 µg/g, n (%) | 13/39 (33) | 5/38 (13) | 0.036 |
| CRP (mg/L), median (IQR) | 2.0 (0.8–3.2) | 8.4 (2.0–23.8) | <0.001 |
| ESR (mm/hour), median (IQR) | 6.5 (3.0–17.3) | 17 (8.0–33.0) | 0.003 |
| Total leucocyte count (109/L), median (IQR) | 5.5 (4.8–7.1) | 7.3 (5.9–9.3) | 0.001 |
CRP, C reactive protein; ESR, erythrocyte sedimentation rate; Fcal, faecal calprotectin; IFX, infliximab.